Clinical Trial Update: Rollover Protocol Continued Access to Emtricitabine/Tenofovir Disoproxil Fumarate for Adults in United States [Phase 2]

View source ↗

Summary

This clinical trial update confirms completion of a Phase 2 rollover/continued access protocol for emtricitabine/tenofovir disoproxil fumarate in adults with ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Emtricitabine/Tenofovir disoproxil fumarate (emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2017-06-02